Effect of Plantago on the of pulmonary complications of radiation therapy
Phase 3
Recruiting
- Conditions
- Breast Cancer.Malignant neoplasm of breast
- Registration Number
- IRCT20180617040114N2
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Breast Cancer and Candidate Radiation Therapy
Ages between 17 and 65 years
Life expectancy of more than one year based on estimates of physician or medical team
Physical and mental ability to cooperate in filling out the questionnaire
Exclusion Criteria
People with liver and kidney disease.
People who have a history of allergy to herbal medicines.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Forced Vital Capacity (FVC). Timepoint: Before intervention and three months after intervention. Method of measurement: Spirometry.;Forced Expiratory Volume in the second period (FEV1). Timepoint: Before intervention and three months after intervention. Method of measurement: Spirometry.;Forced Vital Capacity (FVC) Ratio to Forced Expiratory Volume in the second period (FEV1). Timepoint: Before intervention and three months after intervention. Method of measurement: Spirometry.
- Secondary Outcome Measures
Name Time Method Phlegm and mucus in the throat. Timepoint: Before intervention and three months after intervention. Method of measurement: Aspiration.;Score of quality life. Timepoint: Before intervention and three months after intervention. Method of measurement: Quality of Life Questionnaire.